摘要 |
<p>The present invention relates to novel compounds of formula (I) or pharmaceutically acceptable salt thereof: (I), processes for their preparation, intermediates used in these processes, pharmaceutical compositions containing them and their use in therapy, as modulators of dopamine D<SUB>3</SUB> receptors, e.g. to treat drug dependency, as antipsychotic agents, to treat obsessive compulsive spectrum disorders, premature ejaculation or cognition impairment.</p> |
申请人 |
GLAXO GROUP LIMITED;ARISTA, LUCA;CARDULLO, FRANCESCA;CHECCHIA, ANNA;HAMPRECHT, DIETER;MICHELI, FABRIZIO;TEDESCO, GIOVANNA;TERRENI, SILVIA |
发明人 |
ARISTA, LUCA;CARDULLO, FRANCESCA;CHECCHIA, ANNA;HAMPRECHT, DIETER;MICHELI, FABRIZIO;TEDESCO, GIOVANNA;TERRENI, SILVIA |